Article List

WPRIM Management System> DCMS> Chinese Journal of Laboratory Medicine> 2013> > 1

Volume: Issue: 1

1. Appling cell-free fetal DNA and RNA of maternal plasma in non-invasive prenatal diagnosis	Page:14—17
2. PCR-based techniques for the detection of minority mutations	Page:40—45
3. Application of array CGH in genetic diagnosis of clinical complex chromosomal abnormalities	Page:46—49
4. Quality control and hot issues of maternal serum prenatal screening in China	Page:1—5
5. Chromosomal microarray analysis in prenatal diagnosis	Page:6—9
6. The status of pregnancy thyroid screening indicators reference range establishment and methodology research	Page:10—13
7. Several hot topics and thinking about routine examination of domestic coagulation tests	Page:18—21
8. Clinical biochemistry: review and prospect	Page:22—24
9. The current automation of diagnostic laboratories and further action in China	Page:25—28
10. The trend of development of clinical immunology in laboratory medicine	Page:29—31
11. Construction of clinical microbiological laboratory with fast-responsibility	Page:32—35
12. Screening for thyroid disease in pregnancy	Page:36—39
13. The relationship of IL-11 and CTGF expression with the bone metastasis of breast cancer	Page:68—71
14. Meta-analysis of serum HE4 and HE4/CA125 parallel detection for the diagnosis of ovarian cancer	Page:72—76
15. Communication between the clinical laboratory and clinical department should be strengthened by multiple pathways	Page:88—89
16. Analysis of Y chromosome abnormalities and azoospermia factor microdeletions in male infertility	Page:50—52
17. Analysis of genotype resistance mutations sites among 123 antiretroviral-therapy failure in HIV/AIDS patients in Yunnan province, China	Page:53—58
18. Detecting rs12979860 polymorphisms of IL28B gene by AS-PCR in the patients with hepatitis C	Page:59—62
19. Dual channel real-time PCR melting curve analysis-based assay for detecting of anti-tuberculosis drug-resistant mutations in Mycobacterium tuberculosis	Page:63—67
20. Peripheral blood biomarkers in idiopathic pulmonary fibrosis	Page:68—70
21. Quality indicators in clinical laboratories：past, status quo and future	Page:60—63
22. Current situation in laboratory developed tests supervision	Page:55—59
23. Association between PNPLA3 polymorphisms (rs738409) and non-alcoholic fatty liver disease	Page:45—49
24. Preparation of reference materials of total thyroxine	Page:40—44
25. The monitoring and analysis results of 15 clinical laboratory quality indicators from 2011 to 2015	Page:29—33
26. Analysis of 15 quality indicators in clinical laboratory in Zhejiang province	Page:23—28
27. Establishment, monitoring and improvement of indicators of specimen quality in clinical laboratories	Page:10—12
28. Establishment and application of the critical value monitoring platform	Page:7—9
29. Understanding quality roots in improvements within the laboratory：grasping quality starts within laboratory	Page:4—6
30. Research progress on enrichment and isolation of circulating tumor cells using immunomagnetic separation based microfluidic technology	Page:64—67
31. Investigation on serum lipid levels of healthy adult population in Beijing	Page:34—39
32. Establishment of FMEA risk management procedures for blood coagulation tests in clinical laboratories	Page:13—17
33. Laboratory developed tests:current situation & expectation	Page:1—3